Your Complete Monthly Cost Guide for Switching Treatments
Should I Switch From Mounjaro to Wegovy: Understanding Monthly Cost Differences
When evaluating whether you should switch from Mounjaro to Wegovy, the monthly cost structure represents a significant practical consideration. Wegovy follows a mandatory 16-week dose escalation protocol, with each dose level carrying distinct monthly costs. Unlike some weight management treatments with unpredictable pricing, Wegovy's structured approach allows precise budgeting from initiation through maintenance therapy.
The financial commitment varies considerably throughout your treatment journey. Starting at £79.99 monthly for the 0.25mg initiation dose, costs gradually increase to £209.99 monthly once you reach the 2.4mg maintenance dose. This transparent pricing structure helps patients plan their long-term investment in weight management, particularly when compared to the uncertainty some experience with alternative treatments or switching between different therapeutic options.
Wegovy Pricing Structure: Should I Switch From Mounjaro to Wegovy Based on Cost
EverydayMeds offers comprehensive pricing transparency for patients considering whether they should switch from Mounjaro to Wegovy. The dose escalation follows MHRA-approved protocols: 0.25mg (£79.99), 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and 2.4mg maintenance (£209.99). New customers benefit from the FIRST40 discount code applied at checkout, with returning customers accessing DOSE25 for ongoing savings.
Our Getting Started Bundles provide convenience for treatment initiation, including the Intro Duo (0.25mg & 0.5mg) for £169.99 and Progress Duo (0.5mg & 1mg) for £189.99. The Ultimate Stability Trio offers three months of maintenance 2.4mg supply for £649.99, ensuring treatment continuity without monthly reordering. This prescription-only medicine requires clinical assessment through our GPhC-registered pharmacy #9012878.
Clinical Evidence: Should I Switch From Mounjaro to Wegovy Treatment Outcomes
The STEP clinical trial programme provides robust evidence for Wegovy's efficacy in weight management. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, with STEP 5 demonstrating sustained clinically studied weight loss at two years. The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events.
When considering whether you should switch from Mounjaro to Wegovy, it's important to note that direct head-to-head comparisons aren't available due to different trial designs and populations. Wegovy's mechanism as a selective GLP-1 receptor agonist differs from Mounjaro's dual GIP and GLP-1 approach, potentially offering different clinical profiles for individual patients requiring personalised treatment selection.
Wegovy Mechanism: Should I Switch From Mounjaro to Wegovy Based on How It Works
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1 produced in your intestines after eating. This mechanism promotes satiety by slowing gastric emptying and reducing appetite through direct action on brain appetite centres. Unlike dual-receptor treatments, Wegovy's selective GLP-1 activation provides targeted appetite regulation and may reduce food cravings between meals. The once-weekly injection schedule supports treatment adherence, with the FlexTouch pen system designed for convenient self-administration. Clinical effects typically develop gradually over the 16-week dose escalation period, allowing your body to adapt to increasing therapeutic levels while minimising potential side effects.
Ordering Process: Should I Switch From Mounjaro to Wegovy Through EverydayMeds
Switching from Mounjaro to Wegovy through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to evaluate your suitability for treatment transition. Our UK-qualified prescribers review your medical history, current medications, and treatment goals within 3 working days (or 24 hours with express service). Once approved, your prescription-only medicine is dispensed from our GPhC-registered facility and delivered via next-day cold-chain courier to maintain temperature integrity. The process includes detailed injection guidance, dose escalation schedules, and ongoing clinical support throughout your treatment journey. Payment options include individual pen purchases or convenient bundle packages with discount codes applied at checkout.
Storage and Practical Considerations: Should I Switch From Mounjaro to Wegovy
Wegovy requires refrigerated storage at 2-8°C before first use, with a significant practical advantage of remaining stable at room temperature below 30°C for up to 6 weeks once removed from the fridge. This extended room temperature stability exceeds many alternative treatments and supports travel flexibility without compromising medication efficacy. The FlexTouch pen system provides precise dose delivery throughout the escalation protocol, with each pen containing four weekly doses. Dose escalation cannot be accelerated or skipped, requiring patient commitment to the structured 16-week progression to reach therapeutic maintenance levels. Proper injection technique training and rotation of injection sites help optimise treatment outcomes and minimise injection site reactions.
Long-term Monthly Cost Planning: Should I Switch From Mounjaro to Wegovy
Annual cost planning for patients considering whether they should switch from Mounjaro to Wegovy requires understanding the maintenance dose commitment. At the 2.4mg maintenance level, annual costs approximate £2,519 using the DOSE25 returning customer discount code. This represents a predictable ongoing investment in weight management therapy, particularly relevant for patients requiring long-term treatment support.
The STEP 1 extension study indicates that weight regain occurs when treatment is discontinued, with patients regaining approximately two-thirds of lost weight within one year of stopping. This clinical evidence supports viewing Wegovy as a long-term therapeutic commitment rather than a short-term intervention, making monthly cost predictability essential for treatment sustainability and adherence.
Making Your Switch Decision: Should I Switch From Mounjaro to Wegovy
The decision regarding whether you should switch from Mounjaro to Wegovy involves multiple factors beyond monthly cost considerations. Both medications are available from EverydayMeds, and your prescriber can help determine which treatment aligns with your clinical profile, lifestyle requirements, and budget constraints. Wegovy's selective GLP-1 mechanism may suit patients who respond well to incretin-based appetite regulation, while the extended room temperature stability offers practical advantages for frequent travellers. Our clinical team provides comprehensive support throughout treatment transitions, ensuring continuity of care and optimal therapeutic outcomes. Complete your online assessment today to explore whether Wegovy represents the right choice for your weight management goals: https://everydaymeds.co.uk/collections/wegovy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
